SynAct Pharma AB Financial Overview
SynAct Pharma AB's market cap is currently €1.22B. The company's EPS TTM is kr-0.675; its P/E ratio is -10.49; SynAct Pharma AB is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
